Advertisement

Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px
Document › Details

Goodwin Procter LLC. (11/1/17). "Press Release: Ablynx Closes $200 Million Initial Public Offering in the United States".

Region Region United States (USA)
Organisations Organisation Goodwin Procter LLP
  Group Goodwin Procter (Group)
  Organisation 2 Ablynx N.V. (Euronext Brussels: ABLX, Nasdaq: ABLX)
  Group Ablynx (Group)
Products Product legal services
  Product 2 investment banking
Index terms Index term Ablynx–Goodwin Procter: legal services, 201710 supply legal advice on $200m US IPO of Ablynx at Nasdaq by Goodwin
  Index term 2 Ablynx–SEVERAL: investment, 201710 US IPO $200m+$30m net $210.2m with 11.43m+1.715m ADSs at $17.5/ADS at Nasdaq Global Select Market
Persons Person Bloom, Mitchell S. (Goodwin Procter 201711 Partner)
  Person 2 Mutkoski, John M. (Goodwin Procter 201711 Partner)
     


The Life Sciences team advised Ablynx NV [Euronext Brussels and NASDAQ: ABLX] on the closing of its initial public offering totaling $200 million gross proceeds from the sale of 11,430,000 ordinary shares in the form of American Depositary Shares (ADSs) at a price of $17.50 per ADS, before underwriting discounts.

Ablynx also closed the underwriters’ option to purchase an additional 1,714,500 ordinary shares in the form of ADSs at a price of $17.50 per ADS in its U.S. initial public offering, for additional gross proceeds of $30 million, before underwriting discounts. The underwriters exercised their option to purchase additional ADSs, in full, on October 26, 2017. The aggregate gross proceeds of the offering (including the proceeds of the base offering) amount to $230 million.

Ablynx is a biopharmaceutical company engaged in the development of nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs.

The Goodwin team was led by partner Mitch Bloom and included partners John Mutkoski, Seo Salimi, Brian Fairchild; and associates Timothy Hurley, Tiffany Williamson, Kristin Johnston and Alex Varond.

For more information on the offering, please read the press release.


Related Professionals

Mitchell S. Bloom
John M. Mutkoski
Seo Salimi
Brian A. Fairchild
Timothy S. Hurley
Tiffany B. Williamson
Kristin Johnston
Alexander Varond

   
Record changed: 2017-11-19

Advertisement

Picture [LSF] Life-Sciences-France.com – The Business Web Portal 600x80px

More documents for Goodwin Procter (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px